Glaxo, Sanofi pledge 200m Covid doses to global facility
28th Oct 2020 07:15
(Sharecast News) - Pharmaceutical companies GlaxoSmithKline and Sanofi said they had agreed to make 200m doses of their potential Covid-19 vaccine to a worldwide pooled facility.
Read moreWednesday broker round-up
21st Oct 2020 14:19
(Sharecast News) - Learning Technologies Group: Canaccord upgrades to buy with a target price of 150p.
Read moreEli Lilly's Covid-19 antibody treatment shows promise, company says
8th Oct 2020 11:42
(Sharecast News) - US drug giant Eli Lilly's monoclonal antibody treatment is effective in reducing levels of the novel coronavirus in patients and appears to be able to keep them from having to go go the emergency room or hospital, the company said.
Read moreModerna Covid-19 vaccine may be ready for full-scale use by early Q2 2020
1st Oct 2020 09:04
(Sharecast News) - Moderna's Covid-19 vaccine candidate will not be ready by the 3 November presidential elections in the US, but it could be by the end of that month.
Read moreInovio shares crash after FDA places partial hold on Covid-19 trial
28th Sep 2020 13:30
(Sharecast News) - Inovio's phase 2/3 trial of its Covid-19 vaccine candidate was put on partial hold by the US Food and Drug Administration, sending the shares crashing.
Read moreEU agrees to purchase Sanofi/GSK Covid-19 vaccine
18th Sep 2020 11:01
(Sharecast News) - The European Union agreed an advance purchase agreement with Sanofi and GlaxoSmithKline for the companies' potential Covid-19 vaccine.
Read moreJefferies says short-term correction in AstraZeneca may prove misplaced
9th Sep 2020 13:25
(Sharecast News) - Analysts at Jefferies reiterated their 'hold' recommendation for shares of AstraZeneca following the pharma giant's decision to press the pause button on its phase three clinical trial for the Covid-19 vaccine under development alongside the University of Oxford.
Read moreBioNTech and Pfizer announce positive result in pre-clinical trial for Covid-19 vaccine
9th Sep 2020 12:52
(Sharecast News) - One of the Covid-19 vaccine candidates being developed by German outfit BioNTech and Pfizer succeeded in pre-clinical challenge trials.
Read moreAstraZeneca pauses Covid-19 vaccine trial to review safety data
9th Sep 2020 01:13
(Sharecast News) - AstraZeneca paused the phase three clinical trial of the Covid-19 vaccine candidate that it was developing in conjunction with the University of Oxford, in response to a possible unexplained illness in one of the participants.
Read moreTuesday broker round-up
8th Sep 2020 13:34
(Sharecast News) - Hargreaves Lansdown: Berenberg upgrades to buy with a target price of 1,915.0p.
Read moreGlobal pharma bosses vow to put science first in race for Covid-19 vaccine
8th Sep 2020 11:52
(Sharecast News) - The bosses of nine of the world's largest pharmaceutical companies pledged to put science and safety first in the race to find a vaccine for Covid-19.
Read moreSector movers: Big pharma, support services pace gains
7th Sep 2020 14:57
(Sharecast News) - Big Pharma paced gains in London at the start of the week, led by shares in Dechra Pharmaceuticals after the veterinary drugs maker hiked its dividend payout following what it described as an "encouraging" start to its new financial year.
Read moreRussian vaccine candidate obtains positive peer reviews
4th Sep 2020 15:17
(Sharecast News) - Russia's Covid-19 vaccine candidate generated an immune response without any adverse side effects, according to a peer-reviewed study.
Read moreWHO does not expect mass Covid-19 vaccinations before mid-2021
4th Sep 2020 12:28
(Sharecast News) - The World Health Organization said on Friday it does not expect widespread vaccinations for Covid-19 until at least mid-2021.
Read moreUS CDC tells states to be ready to large-scale vaccination by 1 November
3rd Sep 2020 12:37
(Sharecast News) - America's Centers for Disease Control and Prevention in Atlanta has told state governments to make preparations for the large-scale distribution of a Covid-19 vaccine.
Read more